MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 49 filers reported holding MARKER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $28,938 | -27.7% | 108,830 | 0.0% | 0.00% | – |
| Q3 2022 | $40,000 | +11.1% | 108,830 | 0.0% | 0.00% | – |
| Q2 2022 | $36,000 | -25.0% | 108,830 | 0.0% | 0.00% | – |
| Q1 2022 | $48,000 | -53.4% | 108,830 | 0.0% | 0.00% | – |
| Q4 2021 | $103,000 | -44.0% | 108,830 | 0.0% | 0.00% | – |
| Q3 2021 | $184,000 | -42.5% | 108,830 | -5.1% | 0.00% | – |
| Q2 2021 | $320,000 | -57.3% | 114,693 | -65.8% | 0.00% | – |
| Q1 2021 | $750,000 | +48.2% | 335,058 | -4.0% | 0.00% | – |
| Q4 2020 | $506,000 | -1.4% | 348,982 | +2.1% | 0.00% | – |
| Q3 2020 | $513,000 | -33.0% | 341,733 | -7.6% | 0.00% | – |
| Q2 2020 | $766,000 | +18.4% | 369,889 | +8.7% | 0.00% | – |
| Q1 2020 | $647,000 | -31.8% | 340,221 | +3.3% | 0.00% | – |
| Q4 2019 | $948,000 | -43.5% | 329,248 | +0.3% | 0.00% | – |
| Q3 2019 | $1,678,000 | +71.9% | 328,388 | +166.5% | 0.00% | – |
| Q2 2019 | $976,000 | +170.4% | 123,217 | +125.0% | 0.00% | – |
| Q1 2019 | $361,000 | +16.8% | 54,766 | -1.7% | 0.00% | – |
| Q4 2018 | $309,000 | – | 55,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |